Alexandria M. Meyer, MS, MA, CGC, of Ambry Genetics, Aliso, CA, explains how prostate cancer can be an indicator for hereditary cancer susceptibility and the importance of genetic testing.
Keywords: hereditary prostate cancer, genetic testing
ABOUT THE AUTHOR
Alexandria M. Meyer, MS, MA, CGC, is the Manager of Clinical Learning and Development at Ambry Genetics Corporation in Aliso Viejo, California. She has been a genetic counselor specializing in cancer genetics for over 10 years. She received her Master’s in Medical Genetics from the University of Wisconsin in 2006 and her Master’s in Bioethics from King’s College of London in 2015. Ms. Meyer has had many roles as a genetic counselor, including in public health, clinical practice, and as a genetic specialist for Ambry Genetics. She currently lives in Southern California.
